Atlas Trials

A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2

Clinical trial NCT03908749 · UNKNOWN

Trial details

NCT number
NCT03908749
Sponsor
Anhui Provincial Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
HER2 Positive Breast Carcinoma
Start date
2019-04-10
Primary completion
2020-04-10
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.